Aethlon Medical, Inc. (AEMD)
Nasdaq · Healthcare · Medical Devices
$6.53+1.16%as of Oct 6, 2026, 7:35 AM ET
- Market cap
- $10.5M
- 52-week range
- $1.41 – $39.50
- 52-week change
- −82.33%
- EPS (trailing)
- −$32.97
- Analyst rating
- 3.0 Hold
- Next earnings
- Nov 11, 2026
Fiscal year to Mar 2026
- Net income
- −$7.2M
- Diluted EPS
- −$10.61
- Free cash flow
- −$7.0M
From the company’s annual report on SEC EDGAR.
About Aethlon Medical, Inc.
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.
Headquarters: San Diego, United States · 9 employees · aethlonmedical.com